Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]

Aydan Eroǧlu, A. Ulu, R. Çam, N. Akar

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

In summary, we found that PAI-1 4G/5G polymorphism is associated with the risk of malignant tumor development and we suggest that this polymorphism may contribute to an inherited predisposition to the development of malignancies; however further studies with larger series from diverse ethnic populations are needed to confirm our results.

Original languageEnglish (US)
Pages (from-to)135-136
Number of pages2
JournalJournal of B.U.ON.
Volume12
Issue number1
StatePublished - Jan 2007
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]'. Together they form a unique fingerprint.

  • Cite this

    Eroǧlu, A., Ulu, A., Çam, R., & Akar, N. (2007). Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]. Journal of B.U.ON., 12(1), 135-136.